Most Recent Posts

Military Appreciation Month: ACP Mentor Brad Rossi and Mentee Daniel Kelly

05/30/2024

In honor of Military Appreciation Month, we partnered with ACP to showcase the significance of their free Mentoring Program and its value to the entrepreneurial ecosystem,

READ MORE
MEMBER SPOTLIGHT:

Member Spotlight: F-Prime Capital

07/26/2023
READ MORE

Listen & Learn from Veteran VC CFOs/COOs

11/15/2022
READ MORE

Q3 2022 Stormy Seas Ahead?

11/02/2022
READ MORE

Learning to be an effective leader in the boardroom

09/21/2022
READ MORE

6 Additional Takeaways from the Latest Venture Monitor

08/10/2022

The second quarter of 2022 brought a series of new stories to the U.S. VC ecosystem, with initial narratives revolving around inflation concerns and the tightening monetary environment.

READ MORE

VCs Leading in National Security

07/13/2022

NVCA convened VCs from across the country to discuss innovative solutions that will focus the power of the U.S. startup ecosystem on making our nation more secure.

Why it matters: Better relations between VC-backed startups and the government will be integral in securing peace, saving lives, and deterring future conflict.

READ MORE

NVCA Celebrates Earth Day with VC Leaders in Climate and Sustainability

04/21/2022

In honor of Earth Day, NVCA recognized and celebrated five leading VCs in climate and sustainability investing.

Driving the news: In 2021, 887 U.S.-based climate tech startups raised $27.55 billion in VC funding, more than double 2020’s record of $12.7 billion invested. Young companies play a fundamental role in advancing the country’s effort to address the climate crisis.

READ MORE

New Research Quantifies the Breadth, Growth, and Resilience of Jobs at VC-backed Companies

02/22/2022

From coast to coast, results from our first-of-its-kind study show the VC industry is fueling resilient American jobs.

 

READ MORE

Research Associate – Lab11 Therapeutics

02/01/2022

Lab11 Therapeutics invites applications for part-time Research Associate, particularly interested in candidates with demonstrated academic excellence who are interested in contributing to research programs focused on developing novel treatment of viral diseases.

Why it matters: Researchers help Lab11 Therapeutics develop broad spectrum antivirals.

READ MORE